Enveric Biosciences, Inc. (ENVB) Balance Sheet
ENVB balance sheet, 2025
December 31, 2025 · U.S. dollars$5.1M assets = $918,400 liabilities + $4.2M equity
Both columns are drawn to the same scale: what ENVB owns equals what it owes plus shareholders’ equity. Hover a block for its value.
ENVB financial health
Current ratio5.38
Comfortable · current assets cover current liabilities 5.38×
Equity / assets82.0%
Equity-funded · of assets funded by shareholders
Goodwill & intangibles0.0%
Mostly tangible · of total assets
Descriptive bands, not a rating. Fiscal 2025.
ENVB balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $39.5M2016 | $5.1M2025 | −20.4%/yr | |
| Total liabilities | $27.8M2016 | $918,4002025 | −31.6%/yr | |
| Shareholders’ equity | $11.7M2016 | $4.2M2025 | −10.8%/yr | |
| Cash & short-term investments | $1.5M2016 | $4.7M2025 | +13.8%/yr | |
| Total debt | $5.0M2016 | $63,8202022 | −51.7%/yr | |
| Net cash (debt) | −$3.6M2016 | $17.7M2022 | +$21.2M | |
| Working capital | −$2.6M2016 | $4.0M2025 | +$6.7M | |
| Current ratio | 0.792016 | 5.382025 | +4.58 | |
| Debt / equity | 0.432016 | 0.002022 | −0.43 |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
ENVB assets
Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current
ENVB liabilities and equity
Current liabilitiesLong-term debtOther long-term liabilitiesEquity
ENVB debt vs cash
Total debtCash & ST investmentsNet cash (debt)
Debt includes short- and long-term borrowings and, where reported, lease obligations.
ENVB balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $4.7M | $2.2M | $2.3M | $17.7M | $17.4M | $1.6M | $431,400 | $1.4M | $4.9M | $1.5M |
| Cash & equivalents | $4.7M | $2.2M | $2.3M | $17.7M | $17.4M | $1.6M | $431,400 | $1.4M | $4.9M | $1.4M |
| Short-term investments | — | — | — | — | — | — | — | — | — | $82,908 |
| Receivables | $0 | $0 | $224,607 | $0 | $0 | $6.4M | $6.4M | $7.9M | $8.8M | $8.1M |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $259,216 | $493,558 | $1.1M | $708,053 | $380,838 | $0 | $783,606 | $818,600 | $924,266 | $542,237 |
| Total current assets | $4.9M | $2.7M | $3.6M | $18.4M | $17.7M | $2.3M | $7.6M | $10.1M | $14.6M | $10.1M |
| Property, plant & equipment (net) | $159,234 | $305,777 | $507,377 | $741,302 | $470,734 | $83,128 | $83,128 | $58,892 | $95,048 | $100,241 |
| Goodwill & intangible assets | $0 | $42,182 | $210,932 | $379,686 | $8.5M | $15.5M | $17.3M | $19.5M | $31.4M | $25.9M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $0 | $0 | $0 | $8,879 | $9,399 | $6.1M | $3.5M |
| Total assets | $5.1M | $3.1M | $4.3M | $19.6M | $26.7M | $4.1M | $25.0M | $29.6M | $52.2M | $39.5M |
| Liabilities | ||||||||||
| Accounts payable | $581,020 | $521,747 | $1.2M | $463,275 | $683,393 | $681,250 | $4.7M | $4.4M | $5.3M | $5.1M |
| Short-term debt | — | — | — | $63,820 | $107,442 | $4.9M | $4.9M | $5.2M | $4.8M | $3.5M |
| Deferred revenue | — | — | — | — | — | — | — | — | −$2.6M | — |
| Total current liabilities | $918,400 | $1.5M | $2.3M | $4.0M | $2.1M | $681,250 | $14.4M | $14.7M | $30.4M | $12.7M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.4M | $0 |
| Lease obligations | — | — | $0 | $63,820 | $176,303 | $0 | — | — | — | — |
| Other long-term liabilities | $0 | $0 | $0 | $0 | $2.3M | $0 | $9.6M | $4.2M | $0 | $15.1M |
| Total liabilities | $918,400 | $1.5M | $2.3M | $4.0M | $4.4M | $681,250 | $14.4M | $18.9M | $32.7M | $27.8M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $10,615 | $6,780 | $27,392 | $20,782 | $6,519 | $100,951 | $25,221 | $423,290 | $181,625 | $138,860 |
| Retained earnings (deficit) | −$114.8M | −$106.1M | −$96.5M | −$79.2M | −$60.7M | −$11.8M | −$40.5M | −$34.5M | −$15.0M | −$3.8M |
| Accumulated other comprehensive income | −$580,038 | −$594,517 | −$569,749 | −$536,734 | −$30,802 | −$181,277 | $60,012 | $86,997 | $36,875 | −$7,426 |
| Minority interest | — | $0 | $0 | $885,028 | — | — | — | — | — | — |
| Total shareholders' equity | $4.2M | $1.6M | $2.0M | $15.6M | $22.3M | $3.4M | $10.6M | $10.8M | $19.4M | $11.7M |
| Key figures | ||||||||||
| Total debt | — | — | — | $63,820 | $176,303 | $4.9M | $4.9M | $5.2M | $7.2M | $5.0M |
| Net cash (debt) | — | — | — | $17.7M | $17.2M | −$3.3M | −$4.4M | −$3.8M | −$2.3M | −$3.6M |
| Working capital | $4.0M | $1.2M | $1.2M | $14.4M | $15.7M | $1.6M | −$6.8M | −$4.6M | −$15.7M | −$2.6M |
| Tangible book value | $4.2M | $1.6M | $1.7M | $15.2M | $13.8M | −$12.1M | −$6.7M | −$8.7M | −$11.9M | −$14.2M |
| Current ratio | 5.38 | 1.84 | 1.53 | 4.61 | 8.51 | 3.35 | 0.53 | 0.68 | 0.48 | 0.79 |
| Quick ratio | 5.09 | 1.50 | 1.07 | 4.44 | 8.33 | 11.69 | 0.47 | 0.63 | 0.45 | 0.75 |
| Debt / equity | — | — | — | 0.00 | 0.01 | 1.43 | 0.46 | 0.48 | 0.37 | 0.43 |
| Equity / assets | 82.0% | 51.7% | 45.5% | 79.6% | 83.5% | 83.4% | 42.5% | 36.3% | 37.3% | 29.5% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $8.3M | $4.9M | $4.7M | $3.8M | $2.8M | $4.3M | $2.2M | $3.1M | $3.5M | $6.4M | $2.3M | $4.3M |
| Cash & equivalents | $8.3M | $4.9M | $4.7M | $3.8M | $2.8M | $4.3M | $2.2M | $3.1M | $3.5M | $6.4M | $2.3M | $4.3M |
| Receivables | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $17,758 | $299,316 | $455,780 | $224,607 | $0 |
| Inventory | $0 | $4,678 | $0 | $0 | $65,413 | $0 | $0 | −$17,758 | $0 | −$455,780 | $0 | $0 |
| Other current assets | $497,029 | $461,652 | $259,216 | $407,946 | $392,143 | $540,405 | $493,558 | $1.2M | $1.7M | $1.9M | $1.1M | $1.6M |
| Total current assets | $8.8M | $5.4M | $4.9M | $4.2M | $3.3M | $4.8M | $2.7M | $4.3M | $5.5M | $8.2M | $3.6M | $5.8M |
| Property, plant & equipment (net) | $81,929 | $119,927 | $159,234 | $196,521 | $241,082 | $267,279 | $305,777 | $367,689 | $405,114 | $452,228 | $507,377 | $539,152 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $42,182 | $84,368 | $126,556 | $168,744 | $421,653 | $253,120 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $68,745 | $26,438 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1 | $0 | $0 |
| Total assets | $8.9M | $5.5M | $5.1M | $4.4M | $3.5M | $5.1M | $3.1M | $4.8M | $6.1M | $8.8M | $4.3M | $6.6M |
| Liabilities | ||||||||||||
| Accounts payable | $682,794 | $280,315 | $581,020 | $683,707 | $1.0M | $669,194 | $521,747 | $576,324 | $459,898 | $1.9M | $1.2M | $1.1M |
| Short-term debt | — | — | — | — | $99,875 | — | — | — | — | — | — | — |
| Total current liabilities | $861,475 | $460,676 | $918,400 | $905,885 | $1.4M | $1.2M | $1.5M | $839,166 | $645,340 | $2.4M | $2.3M | $4.2M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | — | — | — | — | — | — | — | — | — | — | $0 | $0 |
| Other long-term liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total liabilities | $861,475 | $460,676 | $918,400 | $905,885 | $1.4M | $1.2M | $1.5M | $839,166 | $645,340 | $2.4M | $2.3M | $4.2M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $39,358 | $18,875 | $10,615 | $5,183 | $30,260 | $24,716 | $6,780 | $89,949 | $78,785 | $72,939 | $27,392 | $21,818 |
| Retained earnings (deficit) | −$119.5M | −$116.5M | −$114.8M | −$112.7M | −$110.8M | −$108.3M | −$106.1M | −$102.9M | −$100.8M | −$99.0M | −$96.5M | −$93.1M |
| Accumulated other comprehensive income | −$594,681 | −$587,056 | −$580,038 | −$580,945 | −$573,531 | −$598,004 | −$594,517 | −$534,998 | −$566,495 | −$551,843 | −$569,749 | −$535,619 |
| Total shareholders' equity | $8.1M | $5.1M | $4.2M | $3.5M | $2.2M | $3.9M | $1.6M | $4.0M | $5.4M | $6.5M | $2.0M | $2.4M |
| Key figures | ||||||||||||
| Total debt | — | — | — | — | $99,875 | — | — | — | — | — | — | — |
| Net cash (debt) | — | — | — | — | $2.7M | — | — | — | — | — | — | — |
| Working capital | $7.9M | $4.9M | $4.0M | $3.3M | $1.9M | $3.7M | $1.2M | $3.5M | $4.9M | $5.9M | $1.2M | $1.6M |
| Tangible book value | $8.1M | $5.1M | $4.2M | $3.5M | $2.2M | $3.9M | $1.6M | $3.9M | $5.3M | $6.3M | $1.5M | $2.2M |
| Book value per share | $2.03 | $3.35 | $3.94 | — | — | — | — | — | — | — | — | — |
| Shares outstanding | 4.0M | 1.5M | 1.1M | — | — | — | — | — | — | — | — | — |
| Current ratio | 10.21 | 11.67 | 5.38 | 4.60 | 2.43 | 4.08 | 1.84 | 5.17 | 8.55 | 3.48 | 1.53 | 1.39 |
| Quick ratio | 9.63 | 10.66 | 5.09 | 4.15 | 2.09 | 3.63 | 1.50 | 3.73 | 5.89 | 2.88 | 1.07 | 1.02 |
| Debt / equity | — | — | — | — | 0.05 | — | — | — | — | — | — | — |
| Equity / assets | 90.4% | 91.7% | 82.0% | 79.2% | 61.6% | 76.8% | 51.7% | 82.5% | 89.3% | 73.2% | 45.5% | 36.8% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 27, 2026); data from EODHD.
ENVB financial position
At the end of fiscal 2025 (December 31, 2025), Enveric Biosciences had total assets of $5.1 million (up 65.3% from a year earlier), total liabilities of $0.9 million and shareholders' equity of $4.2 million. Its current ratio was 5.38. In the latest quarter (ended June 30, 2026) total assets were $8.9 million and equity $8.1 million.
Related: ENVB income statement, ENVB cash flow statement, ENVB key metrics. See the ENVB stock overview for the latest quote and news.
ENVB balance sheet FAQ
What are Enveric Biosciences's total assets?
Enveric Biosciences reported total assets of $5.1 million at the end of fiscal 2025 (December 31, 2025), compared with $3.1 million a year earlier.
How much cash does Enveric Biosciences have?
Enveric Biosciences held $4.7 million in cash and short-term investments at the end of fiscal 2025.
What is Enveric Biosciences's book value?
Enveric Biosciences's shareholders' equity (book value) was $4.2 million at the end of fiscal 2025.
What is Enveric Biosciences's current ratio?
Enveric Biosciences had current assets of $4.9 million and current liabilities of $0.9 million, a current ratio of 5.38 (it can cover its short-term obligations).